Abstract
A controlled-release drug delivery system can be achieved by incorporating biomolecules within biodegradable nanoparticles (NPs) and further inclusion of such carriers into tissue-engineered scaffolds. The objective of this study was to evaluate the effect of adding poly(lactic-co-glycolic) acid (PLGA) NPs on a chitosan-bioactive glass (CH-BG) scaffold. Two groups of scaffolds, with and without NPs, were prepared by lypholization and the drug release was studied. It was shown that the incorporation of the NPs increased the mechanical strength of the scaffolds, while the swelling behavior slightly decreased as a result of adding NPs. The results demonstrated that while the addition of NPs did not affect the morphology of the scaffold, the system had a potential to be used as a controlled-release platform of model drugs to the bone once implanted. Furthermore, the ability to control NP size together with targeted delivery may result in favorable biodistribution and development of clinically relevant targeted therapies.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
